PROF vs TFC · rev $10.7M vs rev $24.54B
Profound Medical Corp (PROF) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
TFC (TFC) common stock.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
PROF currently screens at market cap $238.7M. TFC currently screens at market cap $0.
Not investment advice. Open the PROF and TFC stock pages for the full models.
Not investment advice.